Entrar Registro gratuito

Neuland Laboratories Dívida/Patrimônio

Qual é o Dívida/Patrimônio de Neuland Laboratories?

O Dívida/Patrimônio de Neuland Laboratories Limited é 0.73

Qual é a definição de Dívida/Patrimônio?



O índice de endividamento é um índice financeiro que indica a proporção relativa do patrimônio líquido e da dívida usada para financiar os ativos de uma empresa.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dívida/Patrimônio de empresas na Setor Health Care em BSE em comparação com Neuland Laboratories

O que Neuland Laboratories faz?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Empresas com dívida/patrimônio semelhantes a Neuland Laboratories